Cisplatin treatment leads to changes in nuclear protein and microRNA expression
Authors:
- Li SunLSLi Sun
- Xianghong LuXLXianghong Lu
- Zhanghui ChenZCZhanghui Chen
- Penelope J. Duerksen-HughesPenelope J. Duerksen-Hughes
- Hu HuHHHu Hu
- Xinqiang ZhuXZXinqiang Zhu
- Jun YangJYJun Yang
- 1 July 2012
- journal article
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 746 (1) , 66-77
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81172692)
- Zhejiang Provincial Natural Science Foundation (R2100555)
- Ministry of Science and Technology (2009DFB30390)
This publication has 66 references indexed in Scilit:
- New Insights into Neuroblastoma Cisplatin Resistance: A Comparative Proteomic and Meta-Mining InvestigationJournal of Proteome Research, 2010
- Nuclear proteome analysis of cisplatin-treated HeLa cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2010
- An Oncogene-Induced DNA Damage Model for Cancer DevelopmentScience, 2008
- The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based ChemotherapyAnnual Review of Pharmacology and Toxicology, 2008
- A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatmentProteomics, 2007
- Cellular senescence: when bad things happen to good cellsNature Reviews Molecular Cell Biology, 2007
- Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cellsInternational Journal of Gynecological Cancer, 2006
- The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexesPharmacology & Therapeutics, 1987
- CisplatinAnnals of Internal Medicine, 1984
- Cisplatin (cis-diamminedichloroplatinum II)Cancer Treatment Reviews, 1979